Case Number:

IPR2018-01678

Case Type:

IPR

Status:

Final Written Decision

Petitioner:

Mylan Pharmaceuticals Inc.

Patent Owner:

Sanofi-Aventis Deutschland GmbH

Patent Number:

8,992,486

Tech Center:

3700

1. Filed: September 10, 2018 00:00

   Coverage

   1. May 29, 2020

      Mylan Gets More Sanofi Insulin Pen Patents Nixed At PTAB

      Generic-drug maker Mylan convinced the Patent Trial and Appeal Board to nix a handful of Sanofi-Aventis patents Friday covering the Lantus SoloStar disposable insulin injection pen, adding to its past wins in cases related to the same product.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login